 |
Technologiepark Website: www.affimed.com |
| Industry sector: | Biotechnology |
| Products/services: | Bispecific antibodies to activate the innate immune system of patients with cancer (currently in pre-clinical and clinical development) |
| Location(s): | Heidelberg, Germany New York City, USA |
| Date of foundation: | 2000 |
| Number of employees: | 169 |
| About the company/organisation: | Affimed (Nasdaq: AFMD) is a clinical-stage immuno-oncology company committed to give patients back their innate ability to fight cancer by actualizing the untapped potential of the innate immune system. The company’s proprietary ROCK® platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly owned and partnered single agent and combination therapy programs. The ROCK® platform predictably generates customized innate cell engager (ICE®) molecules, which use patients’ immune cells to destroy tumor cells. This innovative approach enabled Affimed to become the first company with a clinical-stage ICE®. Headquartered in Heidelberg, Germany, with offices in New York, NY, Affimed is led by an experienced team of biotechnology and pharmaceutical leaders united by a bold vision to stop cancer from ever derailing patients’ lives. |
| Recruitments per year: | 40 |
| Area of expertise: |
Biowissenschaften Biochemie Biotechnologie Chemie Program Management Quality Assurance Regulatory Affairs Clinical Operations Statistics |
| Last degree: |
PostDoc PhD Master Bachelor Technische Assistenten |
| Desired additional skills (soft skills): | Good English language skills are favorable |
| Career opportunities: | Direct entry |
| Trainee program: | No |
| Contact: | Affimed GmbH Susanne Hering Im Neuenheimer Feld 582 69120 Heidelberg s.hering [at] affimed.com |